Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Operating expenses:
General and administrative expenses	$ 531	$ 504	$ 1,686	$ 1,567
Gain on sale of in-process research and development			(139)	(445)
Total operating expenses	531	504	1,547	1,122
Loss from operations	(531)	(504)	(1,547)	(1,122)
Other income:
Interest income	252	62	606	70
Total other income	252	62	606	70
Net loss and comprehensive loss	$ (279)	$ (442)	$ (941)	$ (1,052)
Net loss per common share - basic	$ (0.02)	$ (0.03)	$ (0.07)	$ (0.08)
Net loss per common share - diluted	$ (0.02)	$ (0.03)	$ (0.07)	$ (0.08)
Weighted-average common shares used to compute basic net loss per common share	14,321	13,410	14,289	13,410
Weighted-average common shares used to compute diluted net loss per common share	14,321	13,410	14,289	13,410